Prognostics In-Med Private Limited, a active private limited company, was established on 10 January 2018 in Pune, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U72900PN2018PTC174234. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.05 Cr and a paid-up capital of ₹1.46 M.
It upholds a compliant status. Its leadership includes Mukund Raghunath (Director), Latha Chandrasekaran Poonamallee (Director), Rajesh Kumar Purushottam (Director). Past directors included Mukund Raghunath. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 4, Golden Galaxy, Survey No. 20/20/5/2 Someshwarwadi, Baner Road, Pashan, Pune, Maharashtra, 411008.
U72900PN2018PTC174234
174234
10 January 2018
₹1.05 Cr
₹1.46 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Prognostics In-Med Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukund Raghunath | Director | 11 Jan 2020 | Current |
| Latha Chandrasekaran Poonamallee | Director | 10 Jan 2018 | Current |
| Rajesh Kumar Purushottam | Director | 10 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Prognostics In-Med Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1504.78% increase. The company also saw a substantial improvement in profitability, with a 42.88% increase in profit. The company's net worth Soared by an impressive increase of 19.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Prognostics In-Med had a promoter holding of 84.91% and a public holding of 15.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Prognostics In-Med, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Prognostics In-Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prognostics In-Med's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Prognostics In-Med Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Prognostics In-Med Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
The activity Mukund Raghunath was appointed as a Director was appointed as a Director on 11 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
Latha Chandrasekaran Poonamallee was appointed as a Director was appointed as a Director on 10 Jan 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.
Progress on Rajesh Kumar Purushottam was appointed as a Director was appointed as a Director on 10 Jan 2018 & has been associated with this company since 7 years 10 months . was documented.
Progress on Prognostics In-Med Private Limited was registered on 10 Jan 2018 with Roc Pune & aged 7 years 10 months as per MCA records. was documented.
In-Med Prognostics got 50 lakh grant for developing a software that can diagnose brain disorders using AI and 3D MRI images. They were also selected as top 20 global science startups in 2016. The founders aim to make brain health diagnostics affordable and accessible in India. They will use deep learning and machine learning for accurate and early detection of disorders like dementia and Alzheimer's. #BrainTech #AffordableHealthcare #InMedPrognostics.
The CIN of Prognostics In-Med Private Limited is U72900PN2018PTC174234.
Prognostics In-Med Private Limited is headquartered at Flat No. 4, Golden Galaxy, Survey No. 20/20/5/2 Someshwarwadi, Baner Road, Pashan, Pune, Maharashtra, 411008.
Prognostics In-Med Private Limited was incorporated on 10 January 2018.
The current directors of Prognostics In-Med Private Limited are
The primary industry of Prognostics In-Med Private Limited is Hospital And Medical Care.
Prognostics In-Med Private Limited is unlisted.
The authorized capital of Prognostics In-Med Private Limited is ₹1.05 Cr, and the paid-up capital is ₹1.46 M.
The compliance status of Prognostics In-Med Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX